Primary |
Contraception |
50.0% |
Drug Use For Unknown Indication |
23.1% |
Drug Exposure Via Breast Milk |
5.3% |
Depression |
4.3% |
Drug Exposure During Pregnancy |
2.4% |
Product Used For Unknown Indication |
1.9% |
Accidental Exposure |
1.4% |
Menopausal Symptoms |
1.4% |
Oral Contraception |
1.4% |
Schizophrenia |
1.4% |
Endodontic Procedure |
1.0% |
Hormone Replacement Therapy |
1.0% |
Hypertension |
1.0% |
Hypothyroidism |
1.0% |
Rheumatoid Arthritis |
1.0% |
Accidental Drug Intake By Child |
0.5% |
Acne |
0.5% |
Anaemia |
0.5% |
Anxiety |
0.5% |
Arthropod Bite |
0.5% |
|
Vaginal Haemorrhage |
23.7% |
Pregnancy On Oral Contraceptive |
20.2% |
Suppressed Lactation |
12.3% |
Weight Decreased |
8.8% |
Accidental Drug Intake By Child |
3.5% |
Off Label Use |
2.6% |
Panic Attack |
2.6% |
Premature Baby |
2.6% |
Somnolence |
2.6% |
Vision Blurred |
2.6% |
Weight Increased |
2.6% |
Cerebrovascular Accident |
1.8% |
Completed Suicide |
1.8% |
Depression |
1.8% |
Episcleritis |
1.8% |
Failure To Thrive |
1.8% |
Hospitalisation |
1.8% |
Intra-uterine Death |
1.8% |
Irritability |
1.8% |
Jaundice Cholestatic |
1.8% |
|
Secondary |
Hormone Replacement Therapy |
30.8% |
Contraception |
26.2% |
Drug Use For Unknown Indication |
9.2% |
Product Used For Unknown Indication |
9.2% |
Irritable Bowel Syndrome |
4.6% |
Oestrogen Replacement Therapy |
4.6% |
Hypothyroidism |
3.1% |
Psoriasis |
3.1% |
Rash Erythematous |
3.1% |
Anaemia |
0.8% |
Blood Cholesterol |
0.8% |
Crohn's Disease |
0.8% |
Hyperlipidaemia |
0.8% |
Hypertension |
0.8% |
Lennox-gastaut Syndrome |
0.8% |
Pain |
0.8% |
Smoking Cessation Therapy |
0.8% |
|
Breast Cancer |
22.5% |
Vaginal Haemorrhage |
10.0% |
Hyperlipidaemia |
7.5% |
Myalgia |
7.5% |
Myocardial Infarction |
5.0% |
Pregnancy On Oral Contraceptive |
5.0% |
Transverse Sinus Thrombosis |
5.0% |
Vision Blurred |
5.0% |
Weight Increased |
5.0% |
Anxiety |
2.5% |
Breast Cancer Female |
2.5% |
Breast Cancer In Situ |
2.5% |
Headache |
2.5% |
Lupus-like Syndrome |
2.5% |
Maternal Exposure During Pregnancy |
2.5% |
Pharmaceutical Product Complaint |
2.5% |
Postpartum Depression |
2.5% |
Rash |
2.5% |
Rheumatoid Arthritis |
2.5% |
Systemic Lupus Erythematosus |
2.5% |
|
Concomitant |
Contraception |
22.2% |
Drug Use For Unknown Indication |
12.7% |
Product Used For Unknown Indication |
12.5% |
Anxiety |
5.2% |
Premenstrual Syndrome |
4.7% |
Crohn's Disease |
4.5% |
Hormone Replacement Therapy |
4.3% |
Depression |
3.9% |
Pain |
3.9% |
Acne |
3.4% |
Oral Contraception |
3.2% |
Multiple Sclerosis |
2.8% |
Skin Infection |
2.8% |
Tachycardia |
2.6% |
Premedication |
2.4% |
Asthma |
2.2% |
Colitis Ulcerative |
1.7% |
Headache |
1.7% |
Hypertonic Bladder |
1.7% |
Vaginal Haemorrhage |
1.7% |
|
Pulmonary Embolism |
9.8% |
Vomiting |
9.8% |
Paraesthesia |
7.6% |
Urticaria |
7.6% |
Pain |
6.5% |
Vaginal Haemorrhage |
6.5% |
Angioedema |
5.4% |
Cholecystitis Chronic |
5.4% |
Drug Interaction |
5.4% |
Cholelithiasis |
4.3% |
Deep Vein Thrombosis |
4.3% |
Mouth Ulceration |
4.3% |
Abdominal Pain |
3.3% |
Alopecia |
3.3% |
Anxiety |
3.3% |
Melaena |
3.3% |
Nausea |
3.3% |
Breast Cancer |
2.2% |
Cholecystitis |
2.2% |
Cholecystitis Acute |
2.2% |
|
Interacting |
Contraception |
44.4% |
Drug Use For Unknown Indication |
22.2% |
Acne |
11.1% |
Arthropod Bite |
11.1% |
Depression |
11.1% |
|
Pregnancy |
33.3% |
Pregnancy On Contraceptive |
33.3% |
Pregnancy On Oral Contraceptive |
33.3% |
|